Tag:
Proteome Sciences
Latest Headlines
Latest Headlines
Proteome Sciences shares jump on licensing deal
Proteome Sciences shares rose by 14.9 percent when the news of its stroke biomarkers licensing agreement with Randox Laboratories broke.
Proteome Sciences pushes to grow beyond CRO niche
Despite that anticipated growth, an analyst firm thinks the 40-employee-company's relatively small size may make it harder to lure Big Pharma clients.
Proteome Sciences complete AD biomarker study
Proteome Sciences has moved biomarker research in Alzheimer's disease a step further onward, with the conclusion of its biomarker validation study.
Proteome Sciences makes another deal for biomarker services
Proteome Sciences, based in the U.K., is continuing to form partnerships for its PS Biomarker Services, the latest with Italian therapeutics company Siena Biotech. Proteome Sciences will be Sienna's
Major push on for Parkinson's, Alzheimer's biomarkers
Chemical & Engineering News gives us some good news, for a change, about the possibilities of biomarkers moving from lab to clinic. The thing is, you have to look outside of cancer to find them.
New Icon pact expands biomarker offerings
Icon has gained several new technologies from Proteome Sciences to help it bolster the biomarker work it does for drug developers. "This complements Icon's extensive portfolio of biomarker
